| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |